![](/img/cover-not-exists.png)
Suramab, a novel antiangiogenic agent, reduces tumor growth and corneal neovascularization
Emiliano S. Lopez, Manglio M. Rizzo, J. Oscar Croxatto, Guillermo Mazzolini, Juan E. GalloVolume:
67
Language:
english
Pages:
6
DOI:
10.1007/s00280-010-1457-z
Date:
March, 2011
File:
PDF, 352 KB
english, 2011